ARTEMIS AG -- Excellence in LifeSciences!

Our Supervisory Board –
Expression and Guarantee of our Competence Team

We are proud to have won specialists from the life science sector to become Members of the Supervisory Board of our stockholding company. They will support us in word and deed and will herewith actively influence the success of ARTEMIS AG – and hereby also our clients' and candidates' success.

You can learn more about the members of our Supervisory Board by a mouseclick on the different names.

Sue Andrews

After her graduation as biochemist in England and further diploma in the areas of marketing and management Sue Andrews worked for Bayer UK and Syva Europe from 1987 to 1995.
In 1995 she became Manager Global Marketing with Behring Diagnostics where she additionally acted as Regional Manager Europe. From 1997 onwards Ms. Andrews was Managing Director of Dade Behring Germany and Austria/Central Europe and since mid-2000 Regional Manager for Germany, Switzerland, Austria/Central Europe, the Middle East as well as South Africa.
Since 2001 Sue Andrews has been General Manager with Pharmacia Diagnostics in Freiburg being responsible for the German marketing of the group.

Dieter Lingelbach

Dieter Lingelbach holds an MBA
from Indiana University, supported
by a Fulbright grant. Following school
he joined Booz, Allen & Hamilton
as a Management Consultant in their Duesseldorf and New York offices. His fields of competence were strategy and organization, primarily for Health Care
and Life Science Industries. 4 years later he transferred over to Roche Diagnostics, by the time «Boehringer Mannheim»,
as Head of Strategy/M&A for their new business initiatives in Life Science and Consumer Diagnostics. Shortly after was
he advanced to General Manager for Hestia Pharma GmbH, Boehringer Mannheim’s OTC-subsidiary at the time. Since 1996 he acts as Senior VP respon-sible for Global Marketing at Roche Molecular Biochemicals, one of several business units within Roche Diagnostics. This unit is one of the world’s leading suppliers of biochemical materials and instrument systems to Life Science re-search and related industry. Since April 2003 is he serving as Head of Antibodies by Design, a Division of Morphosys AG,
to advance proteomics research by provi-ding high quality high throughput novel recombinant antibodies.

Dr. Nils Behnke

Dr. Nils Behnke studied and took his doctor's degree at the university of Cologne. He acquired sales and marketing experience in different positions in Germany and the USA. Afterwards, he worked for many years as a management consultant for McKinsey & Company, Inc in the European and North American group for pharma and medical products in the Munich and New Jersey offices advising international pharma and diagnostics producers.
Since 2001 Dr. Behnke has been Member of the Board of Management of CellControl AG, a biotech company in Martinsried.

Jakob Holzhammer

After the classical education as a bank clerk Jakob Holzhammer started his studies at the bank academy to obtain a master's degree in banking business and successfully finalized his studies in 1995 being awarded a prize by the State of Bavaria. In different positions within Raiffeisenbank he could gain experience in several areas of the banking business. Since 1998 Mr. Holzhammer has been Managing Director of Raiffeisenbank Edling, a central branch of Raiffeisenbank Rosenheim eG.

Dr. Thomas Schulze

Dr. Thomas Schulze holds a Ph.D. degree in Biology from the FU Berlin where he worked at the Max-Planck Institute for
Molecular Genetics in Berlin about the regulation of retroviral replication, in particular of HIV-1. As a post-doctoral scholar of the Boehringer Ingelheim Foundation for Basic Medicine he moved to Bayer AG in 1990 and later to Bayer Yakuhin/Japan. For about 9 years, he
was responsible for executing several international Pharma projects in various thera-peutic areas with increasing relevance to Biotechnology. In 1999
Dr. Schulze joined november AG as Business Development Manager, helped preparing the company's IPO and was appointed Member of the Board as Chief Operating Officer in October 2001 being in charge of Business Development, R&D, Sales & Marketing and HR. In June 2004 he joined AVONTEC GmbH as CEO.

Dr. Heike Zschoch

After her biology studies in Würzburg and Darmstadt Dr. Heike Zschoch worked as International Team Manager Microscopy in the Diagnostics Division of E. Merck AG from 1985 to 1991. Then, she changed over to Heidrick & Struggles Inc, Munich, one of the worldwide leading Executive Search Management Consultancies as Consultant Healthcare.
In 1993 she founded the company Personal & Organisation, the predecessor of today's ARTEMIS AG, specialising in the search of professional and executive staff in the life science sector. Between 1995 – 1999 she was Head of the Munich branch of Mühlenhoff & Partner GmbH, Düsseldorf. Today Dr. Heike Zschoch is HR Manager in the Human Capital Management department of PricewaterhouseCoopers in Zurich.

Gerrit Zschoch

After his qualification as a system analyst and his studies of business administration at the European Business School Gerrit Zschoch spent 6 years in different positions (among others in Sales and Marketing Diagnostics and Controlling) with E. Merck KgaA in Darmstadt. Afterwards he worked for SmithKline Beecham as Controller Sales/Marketing, for Avon Cosmetics GmbH as Financial Analyst as well as for Fujisawa Germany as Controller Northern Europe. Since 1995 Gerrit Zschoch has been active as a consultant for ARTEMIS Managementberatung, in April 2002 he became Chairman of the Board of ARTEMIS AG.